American Society of Hematology

You must select a month AND year to filter.

• Contact Your Representative to Support the Medicare Physician Payment Reform Act of 2009
• November 6, 2009

• Beginning January 1, 2010 Medicare payments to doctors are scheduled to be cut 21.2 percent unless Congress intervenes.  Legislation currently before the House of Representatives, the "Medicare Physician Payment Reform Act of 2009," HR 3961, would prevent the Medicare physician payment cut and replace it with a new payment formula.

• Rare Disease Treated Using Gene Therapy (National Public Radio)
• November 6, 2009

• Researchers in France have successfully treated two young boys with a rare but fatal genetic disease. This marks a high point for the field of gene therapy after several well-publicized setbacks.

• Alert: FDA Approves Romidepsin for Injection for the Treatment of Cutaneous T-Cell Lymphoma
• November 6, 2009

• On November 5, 2009, the U.S. Food and Drug Administration granted approval to romidepsin for injection (ISTODAX^®, Gloucester Pharmaceuticals Inc.) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.

• Medicare RAC Program Goes National – What You Need to Know
• November 4, 2009

• Medicare providers across the country are beginning to prepare for the national roll-out of the permanent Medicare Recovery Audit Contractor (RAC) program. Initially established as a demonstration project, the RAC program is scheduled to become a permanent and national program in 2010.

• Drug Warning on Dexferrum (Iron Dextran Injection)
• November 4, 2009

• The Food and Drug Administration (FDA) and American Regent are notifying health-care professionals that anaphylactic-type reactions, including fatalities, have followed the parenteral administration of iron dextran injection.

• Medicare Contractors to Review Claims Data Related to Chemotherapy Administration
• November 4, 2009

• The Centers for Medicare and Medicaid Services (CMS) has directed Medicare contractors to review claims data related to Medicare Part B chemotherapy administration and qualifications of non-physicians who performed Medicare physician services.

• ASH to Honor Inspirational Hematologists With Mentor Awards
• November 3, 2009

• The American Society of Hematology (ASH) is honoring two prominent hematologists with ASH Mentor Awards in recognition of the important role they play in the training and career development of hematologists early in their careers. Stuart H. Orkin, MD, and Arthur W. Nienhuis, MD, will receive their awards during the 51st ASH Annual Meeting in New Orleans.

• The American Society of Hematology Elects New Leadership
• November 3, 2009

• The American Society of Hematology, the world’s largest professional society of blood specialists, welcomes five new officers to its Executive Committee, the governing body of the organization. The officers will begin serving their terms in January 2010.

• Medicare Releases Final 2010 Payment Regulations
• November 2, 2009

• The Centers for Medicare & Medicaid Services released a final rule that updates payment policies and rates under the Medicare Physician Fee Schedule for calendar year 2010, beginning January 1, 2010.

• What ASH Grant Support Has Meant to Me
• November 1, 2009

• 2009 marks the 25th anniversary of the ASH Scholar Award program. Since 1985, the American Society of Hematology has supported many great researchers through this program.

• 2009 Mentor Award Recipients
• November 1, 2009

• The ASH Mentor Award was established in 2006 to recognize hematologists who have excelled at mentoring trainees and colleagues. Those selected to receive the award are chosen because they have shown a sustained commitment to mentoring, have made a significant, positive impact on their trainees’ careers, and have advanced research and patient care in the field of hematology through their trainees and their trainees’ trainees.

• Leukemia Cells Evade the Innate Immune System by Expressing “Don’t Eat Me” Signals
• November 1, 2009

• In back-to-back papers in the journal Cell, two related studies from the laboratory of Dr. Irving Weissman at Stanford University demonstrate that CD47 is expressed on normal hematopoietic stem and progenitor cells and that CD47 expression on leukemia cells is a poor prognostic indicator.

• Headlines from Washington, November-December 2009
• November 1, 2009

• A summary of headlines from Washington.
  

• 2009 Honorific Award Recipients
• November 1, 2009

• Announcement of 2009 Honorific Awards recipients.
  

• Elderly AML: Still Cagey After All These Years
• November 1, 2009

• Acute myeloid leukemia in older populations remains a vexing clinical problem. The incidence of AML dramatically increases after the age of 55.1 Given the shift in demographics in Western populations, this bodes for many more cases of elderly individuals presenting with AML. Unfortunately, the sobering fact is that we still have no effective therapy.
  

< Prev Next > Page 1 of 83